An investigation of clinical features of HBsAg and anti-HBs positive patients with chronic hepatitis B

Song JinYun; Wang JianFang; Wu XuPing; Huang Ling

doi:10.3969/j.issn.1001-5256.2016.11.016

Issue 11

Nov. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(11): 2092-2095

PDF( 1565 KB)

An investigation of clinical features of HBsAg and anti-HBs positive patients with chronic hepatitis B

DOI: 10.3969/j.issn.1001-5256.2016.11.016

Published Date: 2016-11-20

Abstract

Abstract

Objective To investigate the phenomenon of coexistence of HBsAg and anti- HBs and its clinical features,as well as related causes. Methods A total of 2260 persons who underwent physical examination in The Second Affiliated Hospital of Southeast University from February 2011 to February 2014 were enrolled,among whom 830 were diagnosed with chronic hepatitis B. Chemiluminescence microparticle immunoassay was used to screen out 188 patients with coexistence of HBsAg and anti- HBs,and these patients were divided into HBeAg positive group( 101 patients) and HBeAg negative group( 87 patients). Another 200 patients with positive HBsAg and negative anti-HBs were enrolled as controls,among whom 80 were in the HBeAg- positive group and 120 were in the HBeAg- negative group. HBV serological markers,liver function,and viral load were measured and analyzed with reference to clinical manifestations. The chi- square test was used for comparison of categorical data between groups. Results There were five patterns of HBV serological markers in patients with positive HBsAg and anti- HBs,among which positive HBsAg,anti- HBs,HBeAg,and anti- HBc and negative anti- HBe were the most common and accounted for 47. 9%( 90 /188). The overall abnormal rate of liver function parameters was 69. 1%( 130 /188),and the positive rate of HBV DNA was 56. 9%( 107 /188). The two groups with positive HBeAg had a high level of HBV DNA replication,and there was no significant difference in the positive rate of HBV DNA between positive HBsAg and anti- HBs group and control group( P > 0. 05).In the groups with negative HBeAg,there was a significant difference in the proportion of patients with HBV DNA quantitation of > 1 × 105 IU / ml between positive HBsAg and anti- HBs group and control group( P < 0. 05). The sequencing of the S region of HBV showed that among the 80 patients with positive HBsAg and anti- HBs,27 had variations in this region,and the mutation rate reached 33. 7%. The major variation sites in S region included P29 L,S61L,P62 L,I126T / S,Q129 N,M133K,F134 L,G145R / K,L175 S,and L186 H. Conclusion The patients with positive HBsA g and anti- HBs account for a certain proportion in patients with hepatitis B,and the major reason may be variation of viral strains. This situation does not indicate the improvement in disease,and the appearance of anti- HBs may not achieve complete and effective HBsA g clearance. There may be persistent replication of viral DNA,which needs to be taken seriously.
- hepatitis B virus,
- hepatitis B surface antigens,
- hepatitis B antibodies,
- antigenic variation

FullText(HTML)

References(20)

References

[1]MONTINERI A,NIGRO L,LA ROSA R,et al.Treatment induced seroconversion to HBs Ab following HBV reactivation in the imnounosuppressed haematology and oncology patient:a clinical survey of 5 cases in Catania,Italy[J].J Clin Virol,2011,52(4):284-287.

[2]WANG HB,YU HB.An analysis of neutralization reaction in samples with positive anti-HBs and HBsAg[J].J Jilin Med Coll,2013,34(3):183-184.(in Chinese)王海波,于红博.抗-HBs和HBsAg同时阳性样本中和反应分析[J].吉林医药学院学报,2013,34(3):183-184.

[3]ZHANG XN.An explanation of the coexistence of HBsAg and anti-HBs[J].Chin J Exp Clin Infect Dis:Electronic Edition,2009,3(3):334-337.(in Chinese)张晓宁.HBsAg与抗-HBs共存现象的解释[J].中华实验和临床感染病杂志,2009,3(3):334-337.

[4]SAYAN M,SENTURK O,AKHAN SC,et al.Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B[J].Int J Infect Dis,2010,14(Suppl 3):136-141.

[5]LIU W,HU T,WANG X,et al.Coexistence of hepatitis B surface antigen and anti-HBs in Chinese chronic hepatitis B virus patients relating to genotype C and mutations in the S and P gene reverse transcriptase region[J].Arch Virol,2012,157(4):627-634.

[6]LEE BS,CHO YK,JEONG SH,et al.Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009emphasizes the coexistenceof HBsAg and anti-HBs[J].J Med Virol,2013,85(8):1327-1333.

[7]REN MX,MENG QH.Research progress in mechanism of coexistence of HBsAg and HBs Ab in patients with HBV infection[J].J Clin Hepatol,2014,30(4):375-378.(in Chinese)任美欣,孟庆华.HBV感染者HBsAg和抗-HBs双阳性发生机制[J].临床肝胆病杂志,2014,30(4):375-378.

[8]DING F,MIAO XL,LI YX,et al.Mutations in the S gene and in the overlapping reverse transcriptase region in chronic hepatitis B Chinese patients with coexistence of HBsA g and anti-HBs[J].Braz J Infect Dis,2016,20(1):1-7.

[9]LIU Y,ZHANG L,ZHOU JY,et al.Clinical and virological characteristics of chronic hepatitis B patients with coexistence of HBsAg and Anti-HBs[J].PLoS One,2016,11(1):e0146980.

[10]WANG ZG,DENG ZY,GUO JW,et al.Primary research of hepatitis B virus infected patients serum with HBsA g and antiHBs double positive[J].Int J Lab Med,2011,32(13):1456-1457.(in Chinese)王珍光,邓芝云,郭建巍,等.乙型肝炎病毒表面抗原与表面抗体同时阳性的血清学模式初步研究[J].国际检验医学杂志,2011,32(13):1456-1457.

[11]LIN QQ,LIU YC,LIU X.An experimental analysis of positive HBsAg and anti-HBs in measurement of HBsAg,antiHBs,HBeA g,anti-HBe,and anti-HBc levels[J].Lab Med Clin,2013,10(3):332-333.(in Chinese)林青青,刘远程,刘欣.两对半定量检测中HBsAg和抗-HBs同时阳性的实验分析[J].检验医学与临床,2013,10(3):332-333.

[12]JIANG L,CHEN CH,PU XK.Clinical significance of serological pattern and HBV DNA load in patients with positive HBsAg and anti-HBs[J].Curr Physician,2016,22(17):44-45.(in Chinese)蒋莉,陈春华,濮翔科.分析HBsAg和抗-HBs双阳患者血清模式与HBV DNA载量的临床定义[J].当代医学,2016,22(17):44-45.

[13]DING F,YU HG,LI YX,et al.Sequence analysis of the HBV S protein in Chinese patients with coexisting HBsA g and anti-HBs antibodies[J].J Med Virol,2015,87(12):2067-2073.

[14]INOUE J,KONDO Y,WAKUI Y,et al.Reactivation of resolved hepatitis B virus infection with immune escape mutations after long-term corticosteroid therapy[J].Clin J Gastroenterol,2016,9(2):93-98.

[15]LEE KM,KIM YS,KO YY,et al.Emergence of vaccine-induced escape of hepatitis B virus with multiple surface gene mutations in a Korean child[J].J Korean Med Sci,2001,16(3):359-362.

[16]ZHOU ZJ,LEI HB,LONG C.A preliminary analysis of positive serum HBsAg and anti-HBs[J].Int J Lab Med,2012,33(4):497-498.(in Chinese)周正菊,雷鸿斌,龙聪.血清HBsAg、抗-HBs双阳性结果的初步分析[J].国际检验医学杂志,2012,33(4):497-498.

[17]XIE SD,LIU CY,WANG WM,et al.Effect of different concurrence modes of anti-HBs with HBsAg on the effection status heptatitis B viruses[J].Chin J Gastroenterol Hepatol,2006,15(3):244-248.(in Chinese)谢士达,刘成永,王伟民,等.抗-HBs和HBsAg共存的不同模式对乙型肝炎病毒感染的影响[J].胃肠病学和肝病学杂志,2006,15(3):244-248.

[18]MIMMS L.Hepatitis B virus escape mutants:pushing the envelope of chronic hepatitis B virus infection[J].Hepatology,1995,21(3):884-887.

[19]KOHNO H,INOUE T,TSUDA F,et al.Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B[J].J Gen Virol,1996,77(8):1825-1831.

[20]SEO SI,CHOI HS,CHOI BY,et al.Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection:a retrospective cohort study[J].J Med Virol,2014,86(1):124-130.

Relative Articles

[1]	Huaqiang ZHANG, Lixin LIU, Xiaohong GUO. Association of nonalcoholic fatty liver disease with the risk of colorectal adenoma and colorectal cancer: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(7): 1619-1625. doi: 10.3969/j.issn.1001-5256.2021.07.028
[2]	Qiaohong LIU, Yu ZHAO, Yiyang HU. Effect of diet on enterotype-related gut microbiota in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(4): 939-942. doi: 10.3969/j.issn.1001-5256.2021.04.046
[3]	Juan PENG, Liangping LI. Mechanism of action of estrogen and its receptor in the development and progression of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(2): 467-470. doi: 10.3969/j.issn.1001-5256.2021.02.046
[4]	Jinhong TANG, Long WANG. Research advances in the association between nonalcoholic fatty liver disease and colorectal adenomatous polyps[J]. Journal of Clinical Hepatology, 2021, 37(11): 2672-2675. doi: 10.3969/j.issn.1001-5256.2021.11.040
[5]	Yalan LEI, Jian BI, Jingwei MAO. Impact of nonalcoholic fatty liver disease on intestinal immune cells[J]. Journal of Clinical Hepatology, 2021, 37(11): 2667-2671. doi: 10.3969/j.issn.1001-5256.2021.11.039
[6]	Shenglan ZENG, Rongzhen ZHANG, Na WANG, Tingshuai WANG, Liting TAN, Dewen MAO. Effect of diet-gut microbiota axis on nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(11): 2676-2679. doi: 10.3969/j.issn.1001-5256.2021.11.041
[7]	Chenlu ZHAO, Wenxia ZHAO. Influence of estrogen deficiency on metabolic associated fatty liver disease in postmenopausal women[J]. Journal of Clinical Hepatology, 2021, 37(7): 1708-1712. doi: 10.3969/j.issn.1001-5256.2021.07.049
[8]	Tian TIAN, Wenwei HU, Xue LI, Jie WU, Dan ZHANG, Changzheng LI. Association between thyroxine level and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(10): 2357-2363. doi: 10.3969/j.issn.1001-5256.2021.10.020
[9]	Xiangqian HUANG, Xiaomeng YAN, Mingda ZHANG, Jing WU, Jianhong CHEN. Association between nonalcoholic fatty liver disease and colorectal neoplasms[J]. Journal of Clinical Hepatology, 2021, 37(12): 2947-2950. doi: 10.3969/j.issn.1001-5256.2021.12.045
[10]	SUN MengYuan, XIANG XiaoXing. Role of gut microbiota and bile acid pathway in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(12): 2831-2834. doi: 10.3969/j.issn.1001-5256.2020.12.040
[11]	Li HongShan, Hu YiYang. Gut microecology: An important target of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(1): 14-18. doi: 10.3969/j.issn.1001-5256.2020.01.002
[12]	Hui DengCheng, Sun MingYu. Association between nonalcoholic fatty liver disease and gut microbiota based on the theory of gut-liver axis[J]. Journal of Clinical Hepatology, 2020, 36(7): 1627-1630. doi: 10.3969/j.issn.1001-5256.2020.07.039
[13]	Zhang Dan, Zhou Bo, Deng Yi, Wen Yu, Lu: JunYan, Wang JinXiang, Geng ZuoTao, Luo SuFeng, Ying YunYan, Wen DaiYan, Shi ChunJing, Pu GuangYu, Jiang Xin, Ma LanQing. Effect of fenofibrate on the diversity of intestinal flora in a mouse model of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(4): 829-834. doi: 10.3969/j.issn.1001-5256.2020.04.024
[14]	Chuan LiXue, Chang Jiang, Zhao JinHan, Li LuoHua, Yang XuYao, Yu Di. Association between nonalcoholic fatty liver disease and colorectal adenomatous polyps[J]. Journal of Clinical Hepatology, 2020, 36(6): 1299-1303. doi: 10.3969/j.issn.1001-5256.2020.06.022
[15]	Feng Gong, He Na, Mi Man, Li XuePing, Liu ManLing, Fan LiPing, Niu ChunYan. Risk factors for the coexistence of inflammatory bowel disease and nonalcoholic fatty liver disease: A Meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(4): 835-839. doi: 10.3969/j.issn.1001-5256.2019.04.025
[16]	Liu SiFu, Xie ZhengYuan. Association between nonalcoholic fatty liver disease and colorectal tumors[J]. Journal of Clinical Hepatology, 2019, 35(9): 2091-2094. doi: 10.3969/j.issn.1001-5256.2019.09.046
[17]	Zhang XiaXia, Xu HongTuan, Xu YouQing. The natural history and clinical features of nonalcoholic fatty liver disease-related cirrhosis[J]. Journal of Clinical Hepatology, 2018, 34(1): 24-26. doi: 10.3969/j.issn.1001-5256.2018.01.004
[18]	Liu JiaQi, Zhou ShaoMing. Research advances in intestinal flora in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(12): 2453-2456. doi: 10.3969/j.issn.1001-5256.2017.12.045
[19]	Lu Xu, Han Tao, Tian Yao, Lu BoWei, Zhang Qian. Research progress in roles of gut microbiota and bile acid metabolism in development and progression of NAFLD[J]. Journal of Clinical Hepatology, 2014, 30(11): 1225-1228. doi: 10.3969/j.issn.1001-5256.2014.11.034
[20]	Zhu Peng, Xu Zong, Wang YuMing. World Gastroenterology Organisation global guidelines：nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2014, 30(9): 842-845. doi: 10.3969/j.issn.1001-5256.2014.09.002

Supplements(0)

Cited By

Cited by

Periodical cited type(3)

1.	黄嘉卿. NNN-链接护理模式对血小板减少症患者睡眠质量及自我感受影响研究. 世界睡眠医学杂志. 2024(02): 378-381 .
2.	赵静雯，王溶，杨隽芃. 艾尔巴韦格拉瑞韦片治疗继发性丙型肝炎病毒感染的效果观察. 中国处方药. 2023(04): 97-99 .
3.	戴兆东. 直接抗病毒药物对丙型肝炎肝硬化患者的临床疗效分析. 抗感染药学. 2023(12): 1308-1311 .

Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (3544) PDF downloads(511)

An investigation of clinical features of HBsAg and anti-HBs positive patients with chronic hepatitis B

DOI: 10.3969/j.issn.1001-5256.2016.11.016